Tumor Treating Fields therapy could potentiate immunotherapy in non-small-cell lung cancer.

Competing Interests: I have received grants or had contracts with RS Oncology, Bayer, Astex Therapeutics, MSD, Roche, Eli Lilly, BMS, Boehringer Ingelheim; received consulting fees from RS Oncology, MSD, Boehringer Ingelheim; received fees for a speakers bureau for BMS; received payment for expert testimony from Leigh Day; received support for attending meetings from RS Oncology; and participated on an AstraZeneca advisory board. My institution received drugs for research from RS Oncology.